NCT00349297

Brief Summary

Acute dacryocystitis in adults can be a very painful disease and may not respond well to medical therapy. The purpose of this prospective non-randomised study is to determine the microorganisms causing acute dacryocystitis and the antibiotic sensitivities of these organisms. The study also aims to correlate the microbiological findings to the severity of clinical manifestations and evaluate the effectiveness of our current practice of aspiration and empiric systemic antibiotic therapy in treating patients with acute dacryocystitis and hence review whether there is a need to alter current management strategy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Nov 2003

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2003

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

July 5, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 6, 2006

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2008

Completed
Last Updated

May 12, 2010

Status Verified

May 1, 2010

Enrollment Period

4.5 years

First QC Date

July 5, 2006

Last Update Submit

May 11, 2010

Conditions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Acute dacryocystitis patients

You may qualify if:

  • Painful localised fluctuant induration just inferior to the medial canthal tendon of less than 2 weeks duration.

You may not qualify if:

  • Non-fluctuant lacrimal sac swelling
  • Uncooperative patient
  • Unwilling Patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Singapore National Eye Centre

Singapore, 168751, Singapore

Location

MeSH Terms

Conditions

Dacryocystitis

Condition Hierarchy (Ancestors)

Lacrimal Apparatus DiseasesEye Diseases

Study Officials

  • Anshu Arundhati, MRCSED, MMED

    Singapore National Eye Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

July 5, 2006

First Posted

July 6, 2006

Study Start

November 1, 2003

Primary Completion

May 1, 2008

Study Completion

May 1, 2008

Last Updated

May 12, 2010

Record last verified: 2010-05

Locations